MedPage Today (3/15, Susman) reported, "In a study that specifically scrutinized the effects of statin therapy on triglycerides, researchers said that rosuvastatin (Crestor) significantly reduced the blood lipid that has been linked to coronary artery disease better than placebo." In the study, "Mexican patients treated with rosuvastatin 10 mg reduced triglycerides by 26%, while patients treated with rosuvastatin 20 mg reduced triglycerides by 33%. Placebo patients reduced triglycerides by 8%." Epidemiologist Juan Talavera, MD, of the Instituto Mexicano del Seguro Social in Mexico City, said during a poster presentation at the 2010 American College of Cardiology meeting, "In addition, rosuvastatin use significantly improved the artherogenic lipid profile."